The Lancet Global Health, February 2022, Volume 10, Issue 2, Pages e154-e297
Read the current issue of The Lancet Global Health, a monthly open access journal publishing robustly designed original research on all aspects of global health
Read the current issue of The Lancet Global Health, a monthly open access journal publishing robustly designed original research on all aspects of global health
Since 1974 substantial gains in childhood survival have occurred in every global region. We estimate that EPI has provided the single greatest contribution to improved…
Epidermal growth factor receptor (EGFR) and its activated downstream signalling pathways play a crucial role in colorectal cancer development and progression. After four decades of…
The development of an effective HIV vaccine is crucial for controlling the HIV epidemic. UNAIDS estimated that there were 1·5 million new HIV infections and…
Both vaccine regimens were safe, warranting evaluation in larger trials.
Diabetes is a common chronic disease that affects up to 10% of adults worldwide.1 People with diabetes are at high risk for a wide variety…
Statins cause a moderate dose-dependent increase in new diagnoses of diabetes that is consistent with a small upwards shift in glycaemia, with the majority of…
Implementation of mobilisation in the ICU was associated with a less than 3% chance of an adverse event occurring and was not found to increase…
Read the current issue of The Lancet Microbe, providing a destination for the best microbiology-focused clinical research
Both frailty (reduced physiological reserve) and social vulnerability (scarcity of adequate social connections, support, or interaction) become more common as people age and are associated…
Population-wide screening of children for presymptomatic early-stage type 1 diabetes is gaining momentum. Studies have demonstrated feasibility and acceptance, and shown that the rate of…